✦ LIBER ✦

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission

✍ Scribed by J Goh,J Mason,J Chan,M Moradi,J Berek…

Book ID: 126381249
Publisher: Springer (Biomed Central Ltd.)
Year: 2013
Tongue: English
Weight: 64 KB
Volume: 1
Category: Article
ISSN: 2051-1426
DOI: 10.1186/2051-1426-1-S1-P213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2, single-arm study of an autolo

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

✍ Paul LR Mitchell,Michael A Quinn,Peter T Grant… 📂 Article 📅 2014 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 492 KB

Integration of autologous dendritic cell

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

✍ Hilko Ardon; Stefaan Van Gool; Isabel Spencer Lopes; Wim Maes; Raf Sciot; Guido 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 349 KB

A Phase 1 Study of Targeted, Dose-Escala

A Phase 1 Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination with Etoposide As Preparative Therapy for Autologous Stem Cell Transplant in Acute Myeloid Leukemia

✍ Mannis, Gabriel N.; Damon, Lloyd E.; Ai, Weiyun; Andreadis, Charalambos; Gaensle 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 74 KB

ERCC1-Positive Circulating Tumor Cells i

ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance

✍ Kuhlmann, J. D.; Wimberger, P.; Bankfalvi, A.; Keller, T.; Scholer, S.; Aktas, B 📂 Article 📅 2014 🏛 American Association for Clinical Chemistry 🌐 English ⚖ 244 KB

Randomized Phase II trial of two high-do

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study

✍ Patrick J Stiff; Elizabeth J Shpall; P.Y Liu; Sharon P Wilczynski; Natalie S Cal 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 544 KB

High-dose idarubicin, cyclophosphamide a

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB